S
SNIPR Biome
SNIPR Biome is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future
About SNIPR Biome
SNIPR Biome is a pioneering startup in the field of microbial gene therapy, specifically using CRISPR technology. CRISPR is a tool that allows scientists to edit genes, essentially cutting and pasting DNA to correct genetic defects or to introduce new genes. SNIPR Biome is applying this technology to the microbiome, the community of microbes that live in our bodies, to develop new treatments for serious diseases like inflammatory bowel disease, multi-drug resistant infections, and cancer.
Read full description
The company was founded in 2017 and has quickly grown to a team of over 40, mostly PhDs. They have raised $50 million in Series A funding, one of the largest rounds in Europe, from four major European funds. This funding is being used to advance their CRISPR-based microbiome drugs to human clinical trials.
SNIPR Biome operates in the biotechnology market, specifically in the area of gene therapy. Their business model revolves around developing and patenting innovative treatments, with 28 patents already granted in the US. They also recently launched a non-profit patent licensing program to enable further research in the field of CRISPR editing in prokaryotes, which are single-celled organisms like bacteria.
The company is based in Copenhagen, Denmark, and is always on the lookout for new talent to join their team. They describe their working environment as fun, fast-paced, collaborative, and outcome-focused.
At a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- Copenhagen, Denmark
- Employees
- 46
- Open positions
- 3
- Dealroom signal
- 81.8/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Drug Development, Bacteria, Genetics and genomics, Synthetic Biology, Microbiome, Crispr, Gene Therapy, Spinout, Biotech and Pharma
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Aug 2025 | $41M | $250M | Wellington Partners · Lundbeckfonden · SPRIN-D · Cystic Fibrosis Foundation | ↗ |
| DEBTDebt | Dec 2024 | $22M | — | European Investment Bank | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for SNIPR Biome is 1.5K monthly website visits, down 69.4% over the last three months. SNIPR Biome's team grew 4.5% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Lundbeckfonden Emerge
CARB-X
Bill & Melinda Gates Foundation
Horizon Europe
Series A8 investors entered at this stage
Lundbeckfonden
Wellington Partners
Lundbeckfonden Ventures
EQT Life Sciences
North-East Venture
SPRIN-D
Cystic Fibrosis Foundation
North-East Family Office
Series B and later1 investor entered at this stage
European Investment Bank
Other known investors1 additional known investor
Technical University of Denmark
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about SNIPR Biome on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SNIPR Biome’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.